Balaxi Pharmaceuticals P/E Ratio

Current P/E Ratio

52.55

High Valuation

Very High - High growth expectations or significantly overvalued

Balaxi Pharmaceuticals (BALAXI) P/E ratio is 52.55 (High), EPS (TTM) ₹0.26, current price ₹23.55 on NSE vs historical average P/E of 9.13 (100.0th percentile) — Very High - High growth expectations or significantly overvalued.

Current Valuation Metrics

P/E Ratio 52.55

Current Price ₹23.55

EPS (TTM) ₹0.26

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 9.13

Historical Range 0.5 - 42.11

Percentile 100.0%

Sector Context

Sector Average 56.79

Sector Median 31.66

Sector Rank #11 of 199

Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹1.95

Mar 2026 ₹0.11

Jun 2026 ₹0.24

BALAXI P/E Ratio — Valuation Signal & Historical Context

Balaxi Pharmaceuticals P/E 52.55 vs historical average 9.13, range 0.5–42.11 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see BALAXI share price screener.

Stock appears overvalued with PE of 52.55, suggesting caution for new investments
Current PE is 475.7% above historical average

Balaxi Pharmaceuticals P/E Ratio Historical Trend

BALAXI annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 52.55 vs historical average 9.13. Also explore BALAXI share price charts to track price trends across different timeframes.

BALAXI Historical P/E Ratio — EPS, Year-End Price & Valuation

Balaxi Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	42.11	1.71	₹72.00	NSE	High
2024	6.5	13.39	₹87.10	NSE	Low
2022	2.05	50.56	₹103.55	NSE	Low
2021	2.96	43.3	₹128.25	NSE	Low
2020	0.5	31.23	₹15.75	NSE	Low
2019	0.65	9.26	₹6.00	NSE	Low

BALAXI vs Healthcare Peers — P/E Ratio Comparison

Balaxi Pharmaceuticals P/E 52.55 vs Healthcare average 56.79, median 31.66 — range 1.99–747.21.

Sector Average

56.79

Sector Median

31.66

Lowest P/E

1.99

Highest P/E

747.21

Companies

199

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Sunrest Lifescience	SUNREST	1.99	₹66	Low
Murae Organisor	MURAE	2.86	₹41	Low
Colinz Laboratories	COLINZ	3.27	₹9	Low
Phaarmasia	PHRMASI	3.41	₹59	Low
Sun Pharma Advanced Rese…	SPARC	4.03	₹6,361	Low
Dipna Pharmachem	DPL	4.65	₹12	Low
JFL Life Sciences	JFLLIFE	4.95	₹67	Low
Shelter Pharma	SHELTER	5.71	₹56	Low
GKB Ophthalmics	GKB	5.9	₹33	Low
Kabra Drugs	KABRADG	6.29	₹49	Low